Form 4: Amphastar Pharmaceuticals CFO William J. Peters Reports Stock Transactions
SEC Form 4
William J. Peters, CFO, EVP & Treasurer of Amphastar Pharmaceuticals, reports exercising stock options and selling shares under a 10b5-1 trading plan.
Summary
- On March 4, 2025, William J. Peters, CFO, EVP & Treasurer of Amphastar Pharmaceuticals, exercised employee stock options to acquire 7,490 shares of common stock at a price of $13.35.
- He then sold 4,231 shares of common stock at a weighted average price of $27.5385, with individual sales ranging from $27.21 to $28.09.
- Additionally, 1,739 shares were withheld to cover tax liabilities related to the vesting of restricted stock units (RSUs).
- Following these transactions, Peters directly owns 95,624 shares of Amphastar Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The use of a 10b5-1 trading plan suggests a pre-arranged strategy to avoid accusations of insider trading.
Comparison to Industry Standards
- Executive compensation packages often include stock options and RSUs to align management's interests with those of shareholders.
- The use of 10b5-1 trading plans is a common practice among corporate executives to manage their stock holdings while complying with insider trading regulations.
- The reported weighted average sale price of $27.5385 is within a reasonable range given the individual sales prices ranging from $27.21 to $28.09.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership by a key executive.
- The sale of shares could slightly increase the stock's trading volume.
Key Dates
| Date | Description |
|---|---|
| March 14, 2024 | Reporting person adopted a Rule 10b5-1 trading plan. |
| November 30, 2024 | One share acquired under the Issuer's 2014 Employee Stock Purchase Plan. |
| March 4, 2025 | Earliest transaction date: Exercise of stock options, sale of shares, and withholding of shares for tax liability. |
| March 6, 2025 | Date of signature for the Form 4 filing. |
| March 16, 2027 | Expiration date of the employee stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.